Oramed Pharmaceuticals
ORMP
#8974
Rank
โ‚น12.79 B
Marketcap
โ‚น321.04
Share price
-3.66%
Change (1 day)
60.40%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น76.04. In 2024 the company made an earnings per share (EPS) of -โ‚น45.06 a decrease over its 2023 EPS that were of โ‚น13.14.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-264.25%
2024-โ‚น45.06-442.86%
2023โ‚น13.14-114.89%
2022-โ‚น88.2420.51%
2021-โ‚น73.2239.29%
2020-โ‚น52.57-31.71%
2019-โ‚น76.97-4.65%
2018-โ‚น80.738.86%
2017-โ‚น74.16-9.2%
2016-โ‚น81.6729.85%
2015-โ‚น62.898.06%
2014-โ‚น58.205.08%
2013-โ‚น55.383.51%
2012-โ‚น53.51137.5%
2011-โ‚น22.53-60%
2010-โ‚น56.32-0%
2009-โ‚น56.32-16.67%
2008-โ‚น67.59-25%
2007-โ‚น90.12700%
2006-โ‚น11.26303.56%
2005-โ‚น2.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น333.31 338.37%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น193.86 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น548.21-820.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น17.84-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.16-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel